Using nationwide data to examine the relative effectiveness of Covid-19 vaccination against omicron amongst a population with low prior rates of SARS-CoV-2 infection: A cohort study

Using nationwide data to examine the relative effectiveness of Covid-19 vaccination against omicron amongst a population with low prior rates of SARS-CoV-2 infection: A cohort study

Background: We used nationwide data to examine relative vaccine effectiveness (rVE) of the Comirnaty mRNA vaccine (Pfizer–BioNTech (original), hereafter Comirnaty, against the Omicron variants (BA.1 and BA.2) during 2022 in Aotearoa New Zealand (NZ). Method: We analysed a national cohort of 3.15 mil...

Full description

Saved in:
Bibliographic Details
Main Authors: J. Paynter, P. McIntyre, J. Wiki, N. Nghiem, B. Liu, L. Marek, M. Hobbs
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Vaccine: X
Subjects:
Cominarty vaccine
Relative vaccine effectiveness
Omicron
New Zealand
Cohort
Online Access:http://www.sciencedirect.com/science/article/pii/S259013622500018X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S259013622500018X

Similar Items